David Krempa

Insider Reports History

Entity: Individual
Location: 29125 W Field Parkway, Suite 235, Deer Park, IL
Signature: /s/ James R. Gruber
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by David Krempa:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Eton Pharmaceuticals, Inc.	Chief Business Officer	Restricted Stock Units	25.9K	$207K	$7.98	Jan 3, 2025	Direct
Eton Pharmaceuticals, Inc.	Chief Business Officer	Stock Option (Right to buy)	813K			Feb 13, 2024	Direct
Eton Pharmaceuticals, Inc.	Chief Business Officer	Employee Stock Option (Right to Buy)	38.6K			Jan 3, 2025	Direct

Showing 1 to 3 of 3 entries

Insider Reports Filed by David Krempa

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
ETON	Eton Pharmaceuticals, Inc.	Jan 3, 2025	2	$0	4	Jan 6, 2025	Chief Business Officer
ETON	Eton Pharmaceuticals, Inc.	Oct 2, 2024	1	$0	4	Oct 4, 2024	Chief Business Officer
ETON	Eton Pharmaceuticals, Inc.	Feb 13, 2024	1	$0	4	Feb 15, 2024	Chief Business Officer
ETON	Eton Pharmaceuticals, Inc.	Mar 1, 2023	0	$0	3	Mar 8, 2023	Chief Business Officer